NDUFS3 and myopathy: We replaced the missing gene in muscle by systemic injection of recombinant AAV9‐expressing Ndufs3. Injection of young mice (approximately 17 days old) prevented the development of the myopathy while injection of myopathic adult mice (60 days old) reverted the phenotype.